Appetite suppression from semaglutide may also interfere with adequate caloric intake needed to maintain milk supply, creating a potential conflict between medication efficacy and breastfeeding sustainability
This happens because some of your nerves were cut during your surgery
This action enhances feelings of fullness and reduces hunger, making it a valuable tool for patients looking to achieve significant weight loss
Emerging evidence suggests that dual GLP-1/GIP agonists like tirzepatide may offer a more favorable gastrointestinal profile in some patients, potentially improving adherence (Kim et al., 2025)
[DOI] [PubMed] [Google Scholar] 55.Marathe C.S., Rayner C.K., Jones K.L., Horowitz M
Prime/MRx is committed to using our real-world research to help our clients make informed benefit decisions for GLP-1 coverage as they navigate this dynamic landscape. For additional information and study design details, please refer to the year-two abstract